Half a million asthma sufferers in the UK could benefit from a "breakthrough" drug that reduces complications caused by the common cold, it was claimed today.
Severe symptoms due to cold infections are one of the chief reasons why asthma patients end up in hospital.
A trial of the new drug, SNG001, at Southampton University, found it significantly reduced asthma symptoms during the critical first week of infection.
Treatment led to a 65% reduction in the number of patients experiencing moderate worsening of symptoms.
More top news
Friends and family of Steven Wanna have launched a campaign to get him facial reconstruction surgery after he was run over on his birthday.
Helen Plint has the forecast for tonight and tomorrow in the west of the region.
Helen Plint has the forecast for tonight and tomorrow in east of region.